aspirin
acetylsalicyl
acid
first
market
german
chemist
felix
hoffman
scientist
bayer
industri
modifi
commonli
use
sodium
salt
salicyl
acid
acetyl
effort
diminish
digest
side
effect
troubl
father
suffer
rheumatoid
arthriti
medic
soon
enjoy
explos
growth
establish
bayer
pharmaceut
first
modern
pharmaceut
compani
howev
begin
use
aspirin
temper
occurr
variou
side
effect
incid
princip
relat
dose
drug
durat
therapi
despit
side
effect
use
household
remedi
long
establish
prior
birth
modern
pharmaceut
regulatori
agenc
princip
fact
wide
regard
safe
effect
aspirin
grandfath
prescript
overthecount
use
without
perform
myriad
preand
postmarket
randomis
clinic
trial
today
would
requir
new
drug
initi
help
left
medic
use
aspirin
inform
disadvantag
abund
data
randomis
doubleblind
clinic
trial
longterm
use
rel
low
dose
aspirin
prophylaxi
thrombot
vascular
event
affect
heart
brain
organ
prevent
variou
cancer
compar
pauciti
inform
attend
shortterm
use
often
higher
dose
aspirin
main
use
ie
take
short
time
usual
without
prescript
relief
acut
pain
fever
symptom
common
cold
influenza
review
attempt
gather
avail
evid
applic
context
contemporari
use
oldfashion
still
valuabl
drug
hundr
year
worldwid
use
possibl
review
everi
studi
efficaci
aspirin
paper
review
import
paper
publish
past
year
embodi
data
trial
modern
design
systemat
review
consensu
concern
use
drug
prior
time
pain
fever
common
cold
influenza
review
other
efficaci
data
present
far
possibl
use
sourc
data
trial
conduct
specif
indic
group
two
main
head
pain
relief
use
fever
common
cold
influenza
contrast
avail
pool
analys
data
gastrointestin
toler
risk
drug
variou
trial
review
summaris
key
result
conclus
efficaci
toler
record
variou
referenc
clinic
trial
specif
trial
design
data
analysi
statist
methodolog
reader
consult
quot
refer
result
trial
group
use
treat
pain
headach
includ
migrain
toothach
sore
throat
menstrual
pain
back
pain
muscular
joint
mild
arthriti
pain
trial
efficaci
assess
use
set
measur
serv
rel
standard
endpoint
measur
pain
relief
prospect
control
trial
use
cochran
librari
author
compil
systemat
review
pain
relief
par
sum
total
pain
relief
totpar
pain
intens
differ
pid
sum
pain
intens
differ
spid
h
commonli
use
calcul
number
particip
achiev
least
pain
relief
result
use
calcul
rel
efficaci
aspirin
compar
placebo
compar
drug
confid
interv
numberneededto
treat
nnt
subject
achiev
benefit
endpoint
includ
count
number
subject
test
group
use
rescu
medic
employ
varieti
subject
measur
pain
intens
pain
relief
patient
use
visual
analogu
scale
va
record
experi
quantit
emphasi
review
efficaci
toler
aspirin
drug
mention
comparison
migraineth
cochran
analysi
doubleblind
control
clinic
trial
respons
mg
mg
dose
aspirin
asa
given
tablet
effervesc
solut
alon
combin
mg
metoclopramid
manag
migrain
attack
patient
without
aura
major
patient
femal
age
year
migrain
least
month
prior
studi
period
moderatetosever
attacksmonth
diagnosi
migrain
case
agreement
guidelin
issu
intern
headach
societi
ih
five
studi
use
placebo
compar
four
use
activ
compar
five
use
case
activ
compar
sumatriptan
mg
mg
efficaci
activ
compar
superior
placebo
case
aspirin
dose
equal
effect
nnt
painfre
h
headach
relief
headach
relief
asa
vs
placebo
addit
benefit
deriv
addit
mg
metoclopramid
mtc
reliev
headach
combin
reduc
associ
nausea
vomit
compar
asa
alon
sumatriptan
mg
differ
asa
alon
painfre
headach
relief
sumatriptan
mg
better
combin
asa
mtc
painfre
headach
relief
hrelief
data
given
author
conclud
asa
mg
effect
treat
acut
migrain
headach
similar
sumatriptan
mg
mg
addit
metoclopramid
reduc
nausea
vomit
increas
relief
pain
includ
tension
headach
also
known
muscl
contract
headach
stress
headach
etc
cluster
headach
dozen
hisdesign
varieti
current
thought
due
peripher
central
mechan
although
part
perceiv
aris
peripher
site
eight
placebocontrol
studi
use
asa
reliev
headach
subject
diagnosi
migrain
exclud
six
includ
data
effect
activ
compar
well
placebo
trial
briefli
summaris
tabl
look
trial
lowest
dose
aspirin
significantli
superior
placebo
reliev
headach
mg
higher
dose
significantli
superior
placebo
despit
fairli
high
placebo
respons
rate
efficaci
asa
broadli
similar
compar
drug
evid
doserespons
effect
effect
increas
asa
dose
mg
observ
major
differ
efficaci
relat
sever
initi
headach
public
compar
efficaci
mg
effervesc
asa
mg
sumatriptan
migrain
subgroup
analysi
patient
sever
pain
baselin
vs
patient
moder
pain
baselin
show
higher
treatment
respons
drug
moder
pain
baselin
drug
significantli
better
placebo
subgroup
statist
signific
differ
drug
either
group
aspirin
effect
headach
pain
follow
dental
procedur
long
accept
surrog
toothach
pain
follow
extract
impact
molar
tooth
quantifi
studi
analges
efficaci
singl
dose
asa
given
moderatetosever
pain
follow
extract
third
molar
tooth
evalu
four
randomis
doubleblind
placebocontrol
studi
summaris
tabl
asa
clearli
effect
reliev
dental
pain
context
sore
throat
studi
occurr
common
cold
number
symptom
may
also
present
two
placebocontrol
studi
assess
relief
sore
throat
set
first
studi
examin
effect
singl
dose
mg
aspirin
patient
sore
throat
due
respiratori
infect
compar
outcom
placebotr
patient
primari
outcom
measur
sum
total
pain
intens
differ
spid
asa
much
superior
placebo
p
secondari
endpoint
asa
also
achiev
statist
superior
compar
placebo
second
similar
studi
patient
receiv
asa
mg
alon
receiv
asa
mg
mg
caffein
receiv
placebo
doubleblind
condit
evalu
period
patient
use
differ
rate
scale
assess
pain
intens
chang
pain
pain
relief
two
qualiti
throat
pain
ie
swollen
throat
felt
difficulti
swallow
activ
treatment
significantli
effect
placebo
efficaci
measur
min
h
asapluscaffein
superior
asa
alon
specif
h
spid
dimens
asa
highli
significantli
superior
placebo
p
aspirin
clearli
effect
mani
patient
sore
throat
dissolv
asa
tablet
warm
water
gargl
solut
min
swallow
materi
despit
popular
combin
dissolv
asa
topic
local
anaesthet
efficaci
method
use
asa
evalu
efficaci
asa
reliev
dysmenorrhoea
document
earlier
literatur
one
randomis
doubleblind
placebocontrol
trial
two
metaanalys
involv
patient
nineti
women
suffer
pain
cramp
menstruat
particip
studi
take
medic
first
two
period
thereaft
randomis
next
two
period
receiv
identicalappear
tablet
contain
either
asa
mg
subject
paracetamol
mg
subject
placebo
subject
pain
score
rate
scale
four
menstruat
asa
paracetamol
found
equal
significantli
effect
placebo
metaanalysi
control
trial
four
common
nsaid
use
treatment
primari
dysmenorrhoea
efficaci
asa
could
assess
variou
method
studi
encompass
outcom
patient
given
mg
asa
timesday
compar
placebo
respons
rate
ratio
rrr
asa
achiev
least
moder
pain
relief
compar
placebo
ci
though
data
easili
combin
even
earlier
studi
publish
analysi
made
data
relat
pain
femal
genit
origin
postsurg
postepisiotomi
patient
uterin
cramp
caus
receiv
mg
mg
mg
asa
placebo
pain
despit
analysi
mix
bag
patient
statist
signific
benefit
compar
placebo
appar
singl
dose
asa
mg
mg
daili
dose
mg
addit
studi
modern
design
execut
would
help
determin
magnitud
benefit
asa
correct
dose
optim
otc
use
despit
scarciti
data
asa
appear
effect
treatment
dysmenorrhoea
back
pain
muscular
joint
pain
minor
arthriti
joint
pain
despit
common
use
adequ
wellcontrol
studi
publish
literatur
effect
asa
pain
case
back
pain
proper
efficaci
trial
asa
vs
placebo
metaanalysi
trial
efficaci
nsaid
gener
yield
mix
result
drug
use
shortterm
lowback
pain
unknown
caus
presenc
sciatica
nerv
root
symptom
asansaid
gener
ineffect
common
cold
also
known
rhiniti
acuta
catarrhali
cold
coryza
nasopharyng
upper
respiratori
tract
infect
urti
commonli
rhinoviru
corona
viru
cold
caus
influenza
virus
differ
virus
link
influenzalik
ill
asa
trial
cold
includ
patient
varieti
differ
ill
cold
typic
present
runni
nose
cough
sore
throat
chill
occasion
may
accompani
symptom
fever
conjunct
headach
muscl
ach
fatigu
vagu
symptom
condit
review
depth
eccl
cold
influenzalik
may
accompani
chill
real
sensat
chilli
fever
mild
uncommon
transient
true
influenza
symptom
gener
sever
promin
cough
sustain
fever
onset
gastrointestin
symptom
howev
condit
often
confus
onset
cure
common
cold
unlik
influenza
symptom
mild
usual
treat
overthecount
remedi
among
aspirin
drug
believ
reduc
symptom
although
shorten
prevent
diseas
get
cold
one
frequent
reason
patient
consult
physician
two
studi
done
set
cold
alreadi
quot
section
sore
throat
asa
clearli
effect
three
addit
control
trial
asa
use
treat
cold
fever
one
asa
treatment
compar
placebo
two
compar
anoth
activ
treatment
studi
summaris
tabl
agent
caus
ill
identifi
cold
group
probabl
heterogen
may
includ
influenza
viru
ill
well
cold
two
studi
howev
studi
bachert
et
al
worth
care
examin
multicent
randomis
doubleblind
doubledummi
placebocontrol
parallel
group
trial
admit
patient
urti
acut
fever
c
made
well
suit
evalu
antipyrexi
effect
cold
drug
unlik
trial
includ
afebril
patient
fig
reproduc
permiss
clearli
show
time
cours
temperatur
alter
respons
singl
dose
mg
mg
either
asa
paracetamol
approxim
patient
group
primari
measur
efficaci
auc
chang
bodi
temperatur
time
drug
administr
h
postdos
differ
group
shown
fig
statist
signific
p
signific
reduct
also
seen
intens
headach
achi
feverish
discomfort
sinu
sensit
percuss
sore
throat
data
fig
b
provid
unequivoc
evid
efficaci
singl
dose
asa
paracetamol
lower
bodi
temperatur
set
similar
time
cours
temperatur
chang
also
observ
activ
compar
studi
materi
list
summaris
paper
clear
even
singl
dose
asa
possess
abil
reliev
sometim
complet
abolish
pain
varieti
type
sever
also
lower
pyrexia
reliev
mani
vagu
troubl
symptom
attend
common
cold
extent
compar
similar
dose
compet
otc
product
efficaci
reliev
migrain
headach
seem
gener
underr
appear
effect
expens
sumatriptan
amount
credibl
data
otc
product
greatest
document
pain
relief
although
amount
evid
support
asa
use
treat
fever
influenzalik
ill
less
nevertheless
demonstr
efficaci
drug
one
limit
data
mainli
deriv
subject
year
age
though
causal
remain
unproven
wide
held
suspicion
asa
may
involv
pathogenesi
rey
syndrom
recent
year
greatli
limit
paediatr
use
drug
unansw
whether
use
newer
market
form
aspirin
effervesc
tablet
dri
granul
chewabl
tablet
caplet
carbasal
calcium
tablet
prove
headtohead
comparison
trial
signific
clinic
advantag
current
avail
plain
tablet
similarli
scarciti
valuabl
inform
valu
shortterm
use
aspirin
combin
drug
eg
metoclopramid
pseudoephedrin
lidocain
dextromethorphan
vitamin
c
caffein
combin
sold
otc
evalu
efficaci
beyond
scope
review
nevertheless
efficaci
asa
regard
establish
ailment
review
begin
medicin
use
recognis
side
effect
attend
consumpt
aspirin
salicyl
gastrointestin
gi
effect
probabl
frequent
experienc
first
descript
find
ulcer
gastric
lesion
stomach
aspirin
user
gastroscopi
led
realis
gastrointestin
symptom
attend
use
aspirin
might
accompani
frank
mucos
injuri
later
emerg
larg
observ
studi
use
aspirin
nsaid
also
occasion
associ
seriou
gastrointestin
complic
perfor
haemorrhag
obstruct
even
death
although
major
death
occur
elderli
patient
seriou
comorbid
condit
reason
number
death
complic
sole
attribut
aspirin
nsaid
remain
undetermin
probabl
quit
small
gi
complic
aris
lesion
actual
caus
drug
other
aris
antiplatelet
effect
drug
varieti
gi
lesion
caus
bleed
especi
drug
use
combin
higher
dose
longer
period
time
cous
steroid
anticoagul
antiplatelet
medic
detail
account
mani
factor
commonli
lack
epidemiolog
studi
incid
gi
symptom
usual
ignor
larg
number
addit
factor
attend
outcom
aspirin
use
individu
specif
group
exact
risk
dose
aspirin
caus
advers
effect
ae
particular
situat
quit
variabl
gi
recent
review
safeti
cyclooxygenas
inhibitor
drug
gener
pertain
mainli
seriou
event
longterm
use
chronic
condit
limit
outcom
attribut
ulcer
data
direct
relev
paper
furnish
background
vagu
concern
among
physician
member
public
gi
safeti
toler
asa
may
spill
limit
shortterm
use
effect
compound
differ
set
ie
reliev
acut
symptom
pain
fever
cold
otherwis
healthi
adult
aspirin
market
otc
differ
form
variou
dose
mg
mg
mg
etc
differ
countri
acut
shortterm
use
recommend
onetim
dose
mg
mg
employ
daili
dose
mg
market
studi
clinic
trial
data
indic
user
take
singl
dose
use
asa
one
day
comparison
larg
amount
larg
epidemiolog
data
safeti
toler
aspirin
use
chronic
diseas
rel
studi
examin
outcom
set
acut
shortterm
use
mani
trial
report
small
question
qualiti
current
discuss
focu
publish
review
metaanalys
care
pool
result
compar
studi
carri
similar
circumst
conclus
drawn
base
result
fairli
larg
number
subject
earli
public
oxford
examin
advers
effect
singl
dose
aspirin
n
compar
placebo
n
randomis
trial
met
inclus
criteria
studi
also
includ
compar
paracetamol
ibuprofen
although
advers
effect
report
trial
overal
patient
aspirin
patient
placebo
report
least
one
advers
effect
ae
numberneededtoharm
nnth
aspirin
compar
placebo
aspirin
dose
mg
significantli
higher
incid
drowsi
gastric
irrit
report
placebo
nnth
respect
time
franc
appear
first
version
studi
unusu
design
directli
compar
toler
aspirin
paracetamol
ibuprofen
placebo
subject
recruit
gener
practition
studi
reli
almost
entir
data
record
patient
although
least
four
subsequ
public
data
extract
studi
calcul
similar
total
ae
rate
estim
rel
safeti
gi
toler
three
compound
close
compar
find
two
public
summaris
tabl
furnish
differ
estim
seriou
gi
advers
event
sgae
exampl
dyspepsia
make
clear
conclus
elus
estim
higher
report
trial
report
might
due
part
trial
carri
period
furthermor
period
individu
patient
may
consum
differ
rate
differ
number
tablet
suppli
less
patient
complet
day
treatment
result
adjust
consumpt
complianc
anoth
factor
relat
similar
trend
observ
unrel
studi
also
use
patientreport
data
author
studi
comment
patient
report
wrote
method
gener
excess
strong
tendenc
report
advers
clinic
effect
suspect
drugrel
third
attempt
address
gastrointestin
toler
asa
directli
came
studi
took
close
compar
randomis
control
doubleblind
placebocontrol
trial
done
pain
relief
patient
migrain
individu
patient
data
ipd
file
sponsor
trial
bayer
gmbh
leverkusen
germani
data
trial
crossov
design
parallel
group
studi
includ
ipd
databas
trial
compar
mg
asa
placebo
data
retriev
statist
analysi
prepar
tabl
done
independ
contract
compani
clinresearch
gmbh
cologn
germani
among
case
includ
receiv
asa
placebo
overal
ae
rate
asa
placebo
respect
nnh
among
ae
organ
system
affect
gastrointestin
tract
asa
placebo
nnh
advers
drug
reaction
adr
gi
system
lower
asa
placebo
even
rate
may
overestim
mani
adr
nausea
vomit
possibl
due
migrain
major
subject
includ
rather
drug
result
analysi
bore
strike
resembl
earlierquot
oxford
studi
though
drowsi
observ
term
gastric
irrit
previous
report
could
use
direct
comparison
figur
report
gastrointestin
advers
event
giae
gastrointestin
advers
drug
reaction
giadr
nevertheless
placebo
ae
rate
almost
ident
recent
cochran
analysi
pertain
migrain
headach
primarili
concern
efficaci
asa
reliev
headach
caus
migrain
made
attempt
deal
issu
gi
toler
nevertheless
attach
appendix
summaris
ae
publish
studi
report
analys
data
giae
studi
yield
rough
estim
giae
incid
total
case
estim
placebo
gi
ae
rate
possibl
crude
incid
rate
quit
similar
rate
bayer
ipd
studi
look
mani
paper
somnol
occur
ae
studi
involv
migrain
recent
extens
detail
studi
incid
asaassoci
advers
effect
complet
studi
commiss
support
bayer
healthcar
execut
panel
independ
univers
professor
combin
expertis
gastroenterolog
pharmacolog
clinic
trial
design
data
collectionanalysi
statist
clinic
medicin
gener
commiss
bayer
execut
studi
restrict
access
compani
data
addit
one
clinic
scientist
one
statistician
employ
bayer
facilit
panel
access
compani
record
aid
locat
relev
studi
detailsresult
clarifi
inhous
statist
analysi
detail
account
elabor
methodolog
publish
individu
patient
data
obtain
record
clinic
trial
involv
asa
conduct
bayer
prior
march
enter
new
ipd
databas
design
studi
establish
clear
inclus
criteria
trial
consid
suitabl
object
analysi
studi
compar
aspirin
either
paracetamol
ibuprofen
also
includ
relev
widespread
otc
use
primari
endpoint
gi
advers
event
bayer
assign
appropri
meddra
term
select
ae
academ
author
also
defin
addit
group
combin
prefer
term
per
system
organ
class
combin
meddra
term
clinic
relev
design
gi
bleed
dyspepsia
minor
dyspepsia
sever
dyspepsia
abdomin
pain
gastroesophag
reflux
diseas
gerd
relat
symptom
oral
complic
search
identifi
ipd
record
suitabl
analysi
receiv
singl
dose
multipl
dose
regimen
treat
day
half
patient
took
daili
dose
asa
mg
mg
dose
paracetamol
mg
mg
mg
ibuprofen
mg
mg
use
comparison
studi
patient
year
age
older
limit
generalis
find
overal
incid
advers
event
low
similar
among
treat
asa
placebo
ci
overal
incid
giae
ad
larg
number
term
also
low
asa
vs
placebo
ci
slight
increas
asa
also
slight
increas
minor
dyspepsia
asa
vs
placebo
ci
signific
increas
major
dyspepsia
symptom
seriou
gi
event
one
gi
bleed
asa
two
placebo
none
consid
drugrel
origin
investig
patient
asa
mgday
ae
asa
mgday
placebo
multipl
dose
administr
also
associ
increas
ae
compar
singl
dose
placebo
rate
similarli
affect
interact
age
gender
event
express
adr
find
essenti
similar
publish
statist
signific
differ
asa
either
activ
treatment
combin
term
dyspepsia
although
or
greater
comparison
ibuprofen
asa
vs
paracetamol
risk
dyspepsia
asa
slightli
increas
meddra
term
combin
term
defin
priori
academ
panel
examin
small
nonsignific
increas
asa
dyspepsia
compar
ibuprofen
note
import
statist
clinic
signific
differ
toler
three
otc
compound
test
use
evalu
brief
mostli
singl
dose
although
otc
market
survey
suggest
aspirin
user
take
tablet
per
month
import
find
across
studi
one
seriou
giae
eg
haemorrhag
perfor
obstruct
death
attribut
asa
although
total
ae
rate
asa
higher
placebo
differ
studi
across
studi
increas
mildtomoder
dyspepsia
achiev
statist
signific
appear
dosedepend
gastric
irrit
could
evalu
appear
minor
increas
sever
dyspepsia
signific
increas
abdomin
pain
analys
larg
ipd
studi
small
nonsignific
increas
incid
abdomin
pain
gerdrel
symptom
basi
extens
analys
asa
appear
quit
effect
well
toler
gi
tract
risk
giae
attend
brief
use
appear
minor
howev
conclus
base
data
shortterm
lowdos
use
appar
healthi
adult
age
yr
seriou
comorbid
ill
hazard
cotherapi
exclud
entri
trial
unless
much
larger
number
patient
includ
seriou
ae
seen
popul
studi
would
detect
studi
brief
modest
dose
asa
hazard
highrisk
situat
close
conclus
present
reflect
actual
consequ
otc
use
asa
gener
popul
await
result
larger
survey
find
suggest
safeti
concern
limit
brief
symptomat
use
effect
drug
